Upgrade to Plus for the average price target, the upside write-up, and the analyst revenue forecast.
Cancel anytime. Secure checkout via Stripe.
| Quarter | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Firm | Action | Rating | Date |
|---|---|---|---|
| Barclays | Maintain | Overweight | Jul 13, 2026 |
| Citigroup | Maintain | Neutral | May 8, 2026 |
| Barclays | Maintain | Overweight | May 7, 2026 |
| Rosenblatt | Maintain | Buy | May 5, 2026 |
| Citigroup | Maintain | Neutral | Apr 29, 2026 |
| Mizuho | Maintain | Neutral | Mar 23, 2026 |
| Rosenblatt | Maintain | Buy | Mar 18, 2026 |
| Keybanc | Maintain | Overweight | Mar 17, 2026 |
| Citigroup | Maintain | Neutral | Feb 6, 2026 |
| Rosenblatt | Maintain | Buy | Feb 5, 2026 |
| RBC Capital | Maintain | Outperform | Feb 5, 2026 |
| JP Morgan | Downgrade | Neutral -> Underweight | Feb 2, 2026 |
Analyst estimates are third-party opinions, not guarantees. For information only.